South Florida Enhanced Track

ACO Name and Location

Orange Accountable Care Organization of South Florida LLC
Previous Names: N/A
14750 NW 77th Court
Suite 308
Miami Lakes, FL 33016

 

ACO Primary Contact

Primary Contact Name Lissette Exposito RN, BSN, MHSA, Founder and President
Primary Contact Phone Number (786) 363-8500
Primary Contact Email Address Lissette.Exposito@orangecaregroup.com

 

Organizational Information

ACO Participants:

ACO Participant Joint Venture?
BROWARD MEDICAL ASSOCIATES OF SOUTH FLORIDA N
CHANDRAKANT SHAH MD PA N
Charles Yanes, M.D., P.A. N
EAST FLORIDA PREMIUM MEDICAL CARE LLC N
GERARDO QUINONEZ, M.D., P.A. N
GUS ARMENAKIS MD PA N
HECTOR M DELGADO D O P A N
IVAN ESPAILLAT MD PA N
JOSE GONZALEZ N
LEVINSON AND CARDENAS, PA N
MARTIN DAYTON DO PA N
Milton A. Jimenez MD PA N
PATRICIA BRAVO MD PA N
PEDRO G. ALVAREZ, D.O., P.A. N
QUALCARE MEDICAL GROUP INC N
ROBERTO URQUIZA M D P A N
ROMEO E ROJAS MD PA N
SOUTH FLORIDA INTERNISTS GROUP PA N
SUSSMAN & STALLER MD PA N

ACO Governing Body:

Member

First Name

Member

Last Name

Member

Title/Position

Member’s Voting Power (Expressed as a percentage) Membership Type ACO Participant Legal Business Name, if applicable
Exposito Lissette President, CEO & Board Chair 24% Board Chair and Voting Member
Quintela, MD Pablo CMIO & Board Member 0% Board Advisor
Jimenez, MD Milton Medical Director & Board Member 25% ACO Participant & Voting Member Milton A. Jimenez MD PA
Armenakis, MD Gus Board Member 25% ACO Participant & Voting Member GUS ARMENAKIS MD PA
Alvarez, DO Pedro Board Member 25% ACO Participant & Voting Member PEDRO G. ALVAREZ, D.O., P.A.
Oliver Mara Board Member 1% ACO Patient and Medicare Beneficiary Representative

 

Key ACO Clinical and Administrative Leadership:

  • ACO Executive: Lissette Exposito
  • Medical Director: Milton Jimenez
  • Compliance Officer: Marc Troisi
  • Quality Assurance/Improvement Officer: Michael Labinski

 

Associated Committees and Committee Leadership:

 

Committee Name Committee Leader Name and Position
Quality and Informatics Pablo Quintela, MD, Chair
Patient Experience Raphael Ruiz, Chair
Finance and Contracting Frank Exposito, Co-Chair

Pablo Quintela, MD, Co-Chair

 

Types of ACO Participants, or Combinations of Participants, That Formed the ACO:

  • ACO professionals in a group practice arrangement
  • Networks of individual practices of ACO professionals

 

Shared Savings and Losses

Amount of Shared Savings/Losses:

  • Second Agreement Period
    • Performance Year 2022, $1,730,829
    • Performance Year 2021, $13,112,590
  • First Agreement Period
    • Performance Year 2020, $16,161,631
    • Performance Year 2019, $6,692,187
    • Performance Year 2018, $3,172,313
    • Performance Year 2017, $2,643,135

Shared Savings Distribution:

  • Second Agreement Period
    • Performance Year 2022
      • Proportion invested in infrastructure: 20%
      • Proportion invested in redesigned care processes/resources: 20%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2021
      • Proportion invested in infrastructure: 20%
      • Proportion invested in redesigned care processes/resources: 20%
      • Proportion of distribution to ACO participants: 60%
    • First Agreement Period
      • Performance Year 2020
        • Proportion invested in infrastructure: 20%
        • Proportion invested in redesigned care processes/resources: 20%
        • Proportion of distribution to ACO participants: 60%
      • Performance Year 2019
        • Proportion invested in infrastructure: 20%
        • Proportion invested in redesigned care processes/resources: 20%
        • Proportion of distribution to ACO participants: 60%
      • Performance Year 2018
        • Proportion invested in infrastructure: 20%
        • Proportion invested in redesigned care processes/resources: 20%
        • Proportion of distribution to ACO participants: 60%
      • Performance Year 2017
        • Proportion invested in infrastructure: 20%
        • Proportion invested in redesigned care processes/resources: 20%
        • Proportion of distribution to ACO participants: 60%

 

Quality Performance Results

2022 Quality Performance Results:

Quality performance results are based on CMS Web Interface

 

Measure # Measure Name Rate ACO Mean
001 Diabetes: Hemoglobin A1c (HbA1c) Poor Control2 10.75 12.46
134 Preventative Care and Screening: Screening for Depression and Follow-up Plan 80.89 74.38
236 Controlling High Blood Pressure 84.32 74.87
318 Falls: Screening for Future Fall Risk 91.55 87.03
110 Preventative Care and Screening: Influenza Immunization 83.92 80.52
226 Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention 94.74 80.97
113 Colorectal Cancer Screening 91.19 73.63
112 Breast Cancer Screening 83.57 75.11
438 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 85.23 84.24
370 Depression Remission at Twelve Months 12.50 15.50
321 CAHPS for MIPS3 N/A N/A
479 Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups2 0.1645 0.1540
MCC1 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions for ACOs (MCC)2 30.49 33.99

 

For previous years’ Financial and Quality Performance Results, please visit: data.cms.gov

 

Payment Rule Waivers

  • Skilled Nursing Facility (SNF) 3-Day Rule Waiver:
    • Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR § 425.612.

 

Didn’t find what you’re looking for?
Contact Us with questions, comments, and requests.